Cover Page
Cover Page - shares | 9 Months Ended | |
Sep. 30, 2022 | Dec. 02, 2022 | |
Document Information [Line Items] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Sep. 30, 2022 | |
Document Fiscal Year Focus | 2022 | |
Document Fiscal Period Focus | Q3 | |
Current Fiscal Year End Date | --12-31 | |
Entity Registrant Name | GLOBAL STAR ACQUISITION INC. | |
Entity Central Index Key | 0001922331 | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | Yes | |
Entity Shell Company | false | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Ex Transition Period | false | |
Entity File Number | 001-41506 | |
Entity Tax Identification Number | 84-2508938 | |
Entity Incorporation, State or Country Code | DE | |
Entity Address, Address Line One | 1641 International Drive Unit 208 | |
Entity Address, City or Town | McLean | |
Entity Address, State or Province | VA | |
Entity Address, Postal Zip Code | 22102 | |
City Area Code | (703) | |
Local Phone Number | 790-0717 | |
Units Each Consisting Of One Share Of Class A Common Stock And One Redeemable Warrant [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Units, each consisting of one share of Class A common Stock and one Redeemable Warrant | |
Trading Symbol | GLSTU | |
Security Exchange Name | NASDAQ | |
Class A Common Stock 0.0001 Par Value Per Share [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Class A Common Stock, $0.0001 par value per share | |
Trading Symbol | GLST | |
Security Exchange Name | NASDAQ | |
Redeemable Warrants Each Whole Warrant Exercisable For One Share Of Class A Common Stock At An Exercise Price Of 11.50 Per Share [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per shar | |
Trading Symbol | GLSTW | |
Security Exchange Name | NASDAQ | |
Rights Exchangeable Into One Tenth Of One Share Of Class A Common Stock [Member] | ||
Document Information [Line Items] | ||
Title of 12(b) Security | Rights, exchangeable into one-tenth of one share of Class A common stock | |
Trading Symbol | GLSTUR | |
Security Exchange Name | NASDAQ | |
Redeemable Class A Common Stock [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 9,200,000 | |
Non-Redeemable Class A Common Stock [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 456,255 | |
Common Class B [Member] | ||
Document Information [Line Items] | ||
Entity Common Stock, Shares Outstanding | 2,875,000 |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Sep. 30, 2022 | Dec. 31, 2021 | |
Current Assets: | |||
Cash | $ 1,397,490 | $ 0 | |
Due from Sponsor | 10,530 | 25,000 | |
Prepaid expenses | 10,000 | 25,071 | |
Other current assets | 263,473 | 0 | |
Total Current Assets | 1,681,493 | 50,071 | |
Investments held in the Trust Account | 82,043,907 | 0 | |
Deferred offering costs | 0 | 31,000 | |
Other assets | 103,580 | 0 | |
Total Assets | 83,828,980 | 81,071 | |
Current Liabilities: | |||
Accounts payable and accrued expenses | 456,833 | 0 | |
Accrued offering costs | 55,349 | 15,000 | |
Accrued franchise tax payable | 150,637 | 1,596 | |
Advances from related party | 0 | 42,384 | |
Due to related party | 112,250 | 0 | |
Overallotment liability | 44,975 | 0 | |
Total Current Liabilities | 820,044 | 58,980 | |
Deferred underwriting commission | 2,800,000 | 0 | |
Total liabilities | 3,620,044 | 58,980 | |
COMMITMENTS AND CONTINGENCIES (Note 6) | |||
Class A common stock subject to possible redemption; 8,000,000 shares (at $10.25 per share) | 82,000,000 | 0 | |
Stockholders' (deficit) equity: | |||
Preferred Stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding | 0 | 0 | |
Additional paid-in capital | 0 | 24,770 | |
Accumulated deficit | (1,791,350) | (2,909) | |
Total Stockholders' (Deficit) Equity | (1,791,064) | 22,091 | |
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' (Deficit) Equity | 83,828,980 | 81,071 | |
Common Class A [Member] | |||
Current Liabilities: | |||
Class A common stock subject to possible redemption; 8,000,000 shares (at $10.25 per share) | 82,000,000 | ||
Stockholders' (deficit) equity: | |||
Common stock | 56 | 0 | |
Common Class B [Member] | |||
Stockholders' (deficit) equity: | |||
Common stock | [1],[2],[3] | $ 230 | $ 230 |
[1]Includes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5).[2]On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5.[3]Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parenthetical) - USD ($) | Sep. 30, 2022 | Jul. 26, 2022 | Dec. 31, 2021 |
Preferred stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | |
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | |
Preferred stock, shares issued | 0 | 0 | |
Preferred stock, shares outstanding | 0 | 0 | |
Common Class A [Member] | |||
Shares subject to possible redemption | 8,000,000 | ||
Shares subject to possible redemption , redemption price per share | $ 10.25 | ||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized | 100,000,000 | 100,000,000 | |
Common stock, shares issued | 556,225 | 0 | |
Common stock, shares outstanding | 556,225 | 0 | |
Common Class B [Member] | |||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | |
Common stock, shares authorized | 10,000,000 | 10,000,000 | |
Common stock, shares issued | 2,300,000 | 2,300,000 | |
Common stock, shares outstanding | 2,300,000 | 2,300,000 | |
Common stock subject to forfeiture | 300,000 | ||
Common Class B [Member] | Sponsor [Member] | |||
Stock forfeiture during the period shares | 575,000 | ||
Stock forfeiture during the period value | $ 0 |
Condensed Statements of Operati
Condensed Statements of Operations - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | ||
EXPENSES | |||||
Administration fee—related party | $ 3,666 | $ 0 | $ 3,666 | $ 0 | |
General and administrative | 257,030 | 19 | 257,763 | 78 | |
TOTAL EXPENSES | 260,696 | 19 | 261,429 | 78 | |
OTHER INCOME (EXPENSE) | |||||
Income earned on Investments held in Trust Account | 43,907 | 0 | 43,907 | 0 | |
Interest income | 126 | 0 | 153 | 0 | |
Change in fair value of overallotment liability | 7,619 | 0 | 7,619 | 0 | |
TOTAL OTHER INCOME | 51,652 | 0 | 51,679 | 0 | |
Net loss | (209,044) | (19) | (209,750) | (78) | |
Common Class A [Member] | |||||
OTHER INCOME (EXPENSE) | |||||
Net loss | $ (54,446) | $ 0 | $ (22,252) | $ 0 | |
Weighted average number of shares of Class A common stock outstanding, basic | 704,348 | 0 | 237,363 | 0 | |
Weighted average number of shares of Class A common stock outstanding, diluted | 704,348 | 0 | 237,363 | 0 | |
Basic net loss per share of Class A common stock | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |
Diluted net loss per share of Class A common stock | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |
Common Class B [Member] | |||||
OTHER INCOME (EXPENSE) | |||||
Net loss | $ (154,598) | $ (19) | $ (187,498) | $ (78) | |
Weighted average number of shares of Class A common stock outstanding, basic | [1],[2],[3] | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
Weighted average number of shares of Class A common stock outstanding, diluted | [1],[2],[3] | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 |
Basic net loss per share of Class A common stock | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |
Diluted net loss per share of Class A common stock | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |
[1]Excludes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5).[2]On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5.[3]Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
Condensed Statements of Opera_2
Condensed Statements of Operations (Parenthetical) - Common Class B [Member] - USD ($) | 3 Months Ended | |||
Jul. 26, 2022 | Sep. 30, 2022 | Sep. 22, 2022 | Dec. 31, 2021 | |
Weighted average number of shares, common stock subject to repurchase or cancellation | 300,000 | |||
Common stock, shares outstanding | 2,300,000 | 2,300,000 | 2,300,000 | |
Sponsor [Member] | ||||
Stock forfeiture during the period shares | 575,000 | |||
Stock forfeiture during the period value | $ 0 |
Statements of Changes in Stockh
Statements of Changes in Stockholders' Equity (Deficit) - USD ($) | Total | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Common Class A [Member] | Common Class A [Member] Common Stock [Member] | Common Class B [Member] | Common Class B [Member] Common Stock [Member] | ||
Beginning Balance, Shares at Dec. 31, 2020 | [1],[2],[3] | 2,300,000 | |||||||
Beginning balance at Dec. 31, 2020 | $ 23,790 | $ 24,770 | $ (1,210) | $ 230 | [1],[2],[3] | ||||
Net (loss) income | (59) | 0 | (59) | $ 0 | [1],[2],[3] | ||||
Ending Balance, Shares at Mar. 31, 2021 | [1],[2],[3] | 2,300,000 | |||||||
Ending balance at Mar. 31, 2021 | 23,731 | 24,770 | (1,269) | $ 230 | [1],[2],[3] | ||||
Beginning Balance, Shares at Dec. 31, 2020 | [1],[2],[3] | 2,300,000 | |||||||
Beginning balance at Dec. 31, 2020 | 23,790 | 24,770 | (1,210) | $ 230 | [1],[2],[3] | ||||
Net (loss) income | (78) | $ 0 | $ (78) | ||||||
Ending Balance, Shares at Sep. 30, 2021 | [1],[2],[3] | 2,300,000 | |||||||
Ending balance at Sep. 30, 2021 | 23,712 | 24,770 | (1,288) | $ 230 | [1],[2],[3] | ||||
Beginning Balance, Shares at Mar. 31, 2021 | [1],[2],[3] | 2,300,000 | |||||||
Beginning balance at Mar. 31, 2021 | 23,731 | 24,770 | (1,269) | $ 230 | [1],[2],[3] | ||||
Net (loss) income | 0 | 0 | 0 | $ 0 | [1],[2],[3] | ||||
Ending Balance, Shares at Jun. 30, 2021 | [1],[2],[3] | 2,300,000 | |||||||
Ending balance at Jun. 30, 2021 | 23,731 | 24,770 | (1,269) | $ 230 | [1],[2],[3] | ||||
Net (loss) income | (19) | 0 | (19) | 0 | (19) | $ 0 | [1],[2],[3] | ||
Ending Balance, Shares at Sep. 30, 2021 | [1],[2],[3] | 2,300,000 | |||||||
Ending balance at Sep. 30, 2021 | 23,712 | 24,770 | (1,288) | $ 230 | [1],[2],[3] | ||||
Beginning Balance, Shares at Dec. 31, 2021 | 0 | 2,300,000 | [1],[2],[3] | ||||||
Beginning balance at Dec. 31, 2021 | 22,091 | 24,770 | (2,909) | $ 0 | $ 230 | [1],[2],[3] | |||
Net (loss) income | (708) | 0 | (708) | $ 0 | $ 0 | [1],[2],[3] | |||
Ending Balance, Shares at Mar. 31, 2022 | 0 | 2,300,000 | [1],[2],[3] | ||||||
Ending balance at Mar. 31, 2022 | 21,383 | 24,770 | (3,617) | $ 0 | $ 230 | [1],[2],[3] | |||
Beginning Balance, Shares at Dec. 31, 2021 | 0 | 2,300,000 | [1],[2],[3] | ||||||
Beginning balance at Dec. 31, 2021 | 22,091 | 24,770 | (2,909) | $ 0 | $ 230 | [1],[2],[3] | |||
Net (loss) income | (209,750) | (22,252) | (187,498) | ||||||
Ending Balance, Shares at Sep. 30, 2022 | 556,225 | 2,300,000 | [1],[2],[3] | ||||||
Ending balance at Sep. 30, 2022 | (1,791,064) | 0 | (1,791,350) | $ 56 | $ 230 | [1],[2],[3] | |||
Beginning Balance, Shares at Mar. 31, 2022 | 0 | 2,300,000 | [1],[2],[3] | ||||||
Beginning balance at Mar. 31, 2022 | 21,383 | 24,770 | (3,617) | $ 0 | $ 230 | [1],[2],[3] | |||
Net (loss) income | 2 | 0 | 2 | $ 0 | $ 0 | [1],[2],[3] | |||
Ending Balance, Shares at Jun. 30, 2022 | 0 | 2,300,000 | [1],[2],[3] | ||||||
Ending balance at Jun. 30, 2022 | 2,385 | 24,770 | (3,615) | $ 0 | $ 230 | [1],[2],[3] | |||
Net (loss) income | (209,044) | 0 | (209,044) | $ (54,446) | 0 | $ (154,598) | 0 | [1],[2],[3] | |
Sale of Units in Public Offering, net of offering costs | 379,243 | 379,243 | 0 | 0 | 0 | [1],[2],[3] | |||
Proceeds from Private Placement Units, net of offering costs | 4,535,275 | 4,535,229 | 0 | $ 46 | 0 | [1],[2],[3] | |||
Proceeds from Private Placement Units, net of offering costs, shares | 456,225 | ||||||||
Proceeds from Sale of Rights, net of costs | 53,094 | 53,094 | 0 | $ 0 | $ 0 | [1],[2],[3] | |||
Class A common stock issued to representative , shares | 100,000 | 0 | [1],[2],[3] | ||||||
Class A common stock issued to representative | 69,000 | 68,990 | 0 | $ 10 | $ 0 | [1],[2],[3] | |||
Remeasurement adjustment of Class A ordinary shares to redemption value | (6,640,017) | (5,061,326) | (1,578,691) | $ 0 | $ 0 | [1],[2],[3] | |||
Ending Balance, Shares at Sep. 30, 2022 | 556,225 | 2,300,000 | [1],[2],[3] | ||||||
Ending balance at Sep. 30, 2022 | $ (1,791,064) | $ 0 | $ (1,791,350) | $ 56 | $ 230 | [1],[2],[3] | |||
[1]Includes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5).[2]On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5.[3]Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
Statements of Changes in Stoc_2
Statements of Changes in Stockholders' Equity (Deficit) (Parenthetical) - Common Class B [Member] - USD ($) | 3 Months Ended | |||
Jul. 26, 2022 | Sep. 30, 2022 | Sep. 22, 2022 | Dec. 31, 2021 | |
Weighted average number of shares, common stock subject to repurchase or cancellation | 300,000 | |||
Common stock, shares outstanding | 2,300,000 | 2,300,000 | 2,300,000 | |
Sponsor [Member] | ||||
Stock forfeiture during the period shares | 575,000 | |||
Stock forfeiture during the period value | $ 0 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Cash Flows From Operating Activities: | ||
Net loss | $ (209,750) | $ (78) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Income earned on Investments held in Trust Account | (43,907) | 0 |
Change in fair value of overallotment liability | (7,619) | 0 |
Changes in operating assets and liabilities: | ||
Prepaid expenses | 15,071 | (71) |
Other current assets | (263,473) | |
Other assets | (103,580) | 0 |
Accounts payable and accrued expenses | 456,833 | (507) |
Accrued franchise tax payable | 149,041 | 0 |
Advances from related party | (42,384) | 656 |
Net Cash Provided By Operating Activities | (49,768) | 0 |
Cash Flows From Investing Activities: | ||
Cash deposited into Trust Account | (82,000,000) | 0 |
Net Cash Used In Investing Activities | (82,000,000) | 0 |
Cash Flows From Financing Activities: | ||
Proceeds from sale of Units in Public Offering, net of underwriting fee | 79,200,000 | 0 |
Proceeds from sale of Private Placement Warrants | 4,563,000 | 0 |
Proceeds from note payable | 185,000 | 0 |
Repayment of note payable | (185,000) | 0 |
Proceeds from Due from Sponsor | 25,000 | 0 |
Due to related party | 112,500 | 0 |
Due from Sponsor | (10,530) | 0 |
Payment of offering costs | (442,462) | 0 |
Net Cash Provided By Financing Activities | 83,447,258 | 0 |
Net change in cash | 1,397,490 | 0 |
Cash at beginning of period | 0 | 0 |
Cash at end of period | 1,397,490 | 0 |
Supplemental disclosure of non-cash financing activities: | ||
Offering costs included in accrued offering costs | 40,349 | 0 |
Deferred underwriters' commission | 2,800,000 | 0 |
Class A ordinary shares remeasurement adjustment | 6,640,017 | 0 |
Fair value of over-allotment option at issuance | $ 52,594 | $ 0 |
Description of Organization and
Description of Organization and Business Operations, Going Concern and Basis of Presentation | 9 Months Ended |
Sep. 30, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Description of Organization and Business Operations, Going Concern and Basis of Presentation | Note 1— Description of Organization and Business Operations, Going Concern and Basis of Presentation Global Star Acquisition Corp. (the “Company”) is a blank check company incorporated in the State of Delaware on July 24, 2019, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. As of September 30, 2022, the Company had not commenced any operations. All activity for the period from July 24, 2019 (inception) through September 30, 2022, relates to organizational activities and identifying a target company for a business combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is Global Star Acquisition I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on September 19, 2022. On September 22, 202 2 one-tenth At the time of the IPO, the underwriters were granted a 45-day Simultaneously with the consummation of the closing of the Offering, the Company consummated the private placement of an aggregate of 456,225 units (the “Private Placement Units”) to Global Star Acquisition I LLC, the sponsor of the Company (the “Sponsor”), at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $4,563,000 (the “Private Placement”) (see Note 4). As of September , , transaction costs amounted to $ consisting of $ of underwriting fees (net of underwriter reimbursements), $ of deferred underwriting fees payable (which are held in a trust account with Continental Stock Transfer & Trust Company acting as trustee (the “Trust Account”) and $ of other offering costs related to the Initial Public Offering. The underwriters were also issued shares (or shares if the over-allotment option is exercised in full) of Class A common stock as representative shares, in connection with this offering. Upon close of the Initial Public Offering, the Company recorded additional issuance costs of $ , the grant date fair value of the shares, with an offset to additional paid-in capital. Cash of $ was held outside of the Trust Account on September 22, 2022 and was available for working capital purposes. In addition, on September 22, 2022, $1,320,903 was due from Sponsor and is available for working capital purposes which was funded on September 27, 2022. As described in Note 6, the $ deferred underwriting fees are contingent upon the consummation of the Business Combination within (or up to from the closing of this offering at the election of the company in nine one-month extensions) from the closing of the Initial Public Offering. Nasdaq rules provide that at least 90% of the gross proceeds from this offering and the sale of the placement units be deposited in a trust account. Of the net proceeds of this offering and the sale of the placement units, $82,000,000, $10.25 per unit, was placed into a trust account in the United States with Continental Stock Transfer & Trust Company acting as trustee and Morgan Stanley Wealth Management acting as investment manager. These proceeds include $2,800,000 in deferred underwriting commissions. The proceeds in the trust account may be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 Following the closing of the Initial Public Offering $29,617 of cash was held outside of the Trust Account available for working capital purposes. As of September 30, 2022, we have available to us $1,397,490 of cash on our balance sheet and a working capital of $861,449. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. In connection with a proposed Business Combination, the Company may seek stockholder approval of a Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against a Business Combination. The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the outstanding shares voted are voted in favor of the Business Combination. The Company will have until September 22, 2023 to consummate a Business Combination. If we do not complete our initial business combination within 12 months from the closing of this offering (or up to 21 months by depositing into the trust account for each one-month pre-initial one-month one-month Our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party (other than the independent public accounting firm) for services rendered or products sold to us, or a prospective target business with which we have entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.10 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.10 per public share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under our indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, we have not asked our sponsor to reserve for such indemnification obligations, nor have we independently verified whether our sponsor has sufficient funds to satisfy its indemnity obligations and believe that our sponsor’s only assets are securities of our company. Therefore, we cannot assure you that our sponsor would be able to satisfy those obligations. None of our officers or directors will indemnify us for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Going Concern Considerations, Liquidity and Capital Resources As of September 30, 2022, the Company had investments held in the Trust Account of $ principally invested in U.S. government securities. As of September 30, 2022, the Company had a working capital of approximately $ , current liabilities of approximately $ and cash of approximately $ . In connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” September 22, 2023 Risks and Uncertainties Management is currently evaluating the impact of the COVID-19 Additionally, as a result of the military action commenced in February 2022 by the Russian Federation and Belarus in the country of Ukraine and related economic sanctions, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. Further, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and related sanctions on the world economy and the specific impact on the Company’s financial position, results of operations and/or ability to consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2 — Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed. As such, the information included in these financial statements should be read in conjunction with the audited financial statements as of June 30, 2022 filed with the SEC on the Registration Statement on Form S-1 No. 333-266387) Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $1,397,490 in cash and no cash equivalents as of September 30, 2022. Cash and Marketable Securities Held in Trust Account As of September 30, 2022, substantially all of the assets held in the Trust Account were held in mutual funds. As of September 30, 2022, the balance in the Trust Account was $82,043,907. Income earned on Investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Offering Costs associated with the Initial Public Offering The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340-10-S99-1 Expenses of Offering Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity 30 The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in At September 30, 2022, the Class A common stock reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 80,000,000 Less: Transaction costs allocated to Class A common stock (4,184,017 ) Proceeds allocated to Public Rights and Warrants (456,000 ) (4,640,017 ) Plus: Remeasurement adjustment of Class A ordinary shares to redemption value 6,640,017 Class A common stock subject to possible redemption $ 82,000,000 Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “ Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not New Law and Changes On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance . Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. At this time, it has been determined that none of the IR Act tax provisions have an impact to the Company’s fiscal 2022 tax provision. The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. The cash at bank is $1,397,490 as of September 30, 2022. Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class two-class The following table reflects the calculation of basic and diluted net loss per common stock (in dollars, except per share amounts): Three Months Ended Three Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (54,446 ) $ (154,598 ) — $ (19 ) Denominator: Basic and diluted weighted average shares outstanding 704,348 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.08 ) $ (0.08 ) (0.00 ) $ (0.00 ) Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (22,252 ) $ (187,498 ) — $ (78 ) Denominator: Basic and diluted weighted average shares outstanding 237,363 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.09 ) $ (0.09 ) (0.00 ) $ (0.00 ) Fair Value of Financial Instruments The Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “ Fair Value Measurements and Disclosures,” Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation” (“ASC 718”), which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. The Company recognizes all forms of stock-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. The Founder Shares were granted subject to certain performance conditions: the occurrence of a Business Combination. Compensation expense related to the Founder Shares is recognized only when the performance conditions are probable of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation expenses are included in general and administrative expenses in the statement of operations. Stock-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. Recently Issued Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “ Debt -Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)” Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Public Offering
Public Offering | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
Public Offering | Note 3 — Public Offering Pursuant to the Initial Public Offering, the Company sold 8,000,000 Units at a price of $10.00 per Unit generating gross proceeds of $80,000,000. Each Unit consists of one share of Common stock, one redeemable warrant (“Public Warrant”) and one right (“Public Right). Each whole Public Warrant will entitle the holder to purchase one share of Common stock at a price of $11.50 per share, subject to adjustment (see Note 7). Each Public Right entitles the holder to receive one-tenth of one share of Common Stock upon the consummation of the business combination. |
Private Placement
Private Placement | 9 Months Ended |
Sep. 30, 2022 | |
Equity [Abstract] | |
Private Placement | Note 4 — Private Placement Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale (the “Private Placement”) of an aggregate of 456,225 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company in the amount of $4,563,000 . The proceeds from the sale of the Placement Units will be added to the net proceeds from the Public Offering held in the Trust Account. The Placement Units are identical to the Units sold in the Public Offering, except for the placement warrants (“Placement Warrants”), as described in Note 7. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Placement Warrants and the rights underlying the Placement Units (“Private Rights”) will expire worthless. |
Related Party Transactions
Related Party Transactions | 9 Months Ended |
Sep. 30, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 5 — Related Party Transactions Class B Common Stock During the year ended December 31, 2021, the Sponsor agreed to purchase 2,875,000 shares of the Company’s Common stock (the “Founder Shares”) for $25,000. On February 14, 2022, the Sponsor received the 2,875,000 shares and paid the Company $25,000 in full satisfaction of the outstanding receivable. The Founder Shares include an aggregate of up to 300,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the number of Founder Shares will equal, on an as-converted The shares transferred to the officers and directors have a grant date fair value of $2.30 per unit or an aggregate of $1,150,000 and the expense associated with these awards will be recognized upon successful business combination. The Company measured the fair value of the shares on the grant date of the award utilizing a valuation model which considers certain assumptions. These assumptions include the probability of completion of a public offering, the probability of initial business combination and estimated concessions. The Sponsor and each Insider agrees that (i) 50% of the Founder Shares (or shares of Common Stock issuable upon conversion thereof) will not be transferred, assigned or sold until the earlier of (A) six months after the date of the consummation of the Company’s initial business combination and (B) the date on which the closing price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination and (i) the remaining 50% of the Founder Shares (or shares of Common Stock issuable upon conversion thereof) will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of the Company’s initial business combination. On September 19, 2022, the Sponsor transferred 400,000 shares to the Company’s three officers and 100,000 shares to the Company’s five directors. Due to Related Party At the close of the Initial Public Offering, a related party deposited $25,000 greater than the agreed upon initial investment. The Company repaid this amount in full and no balance related to this transaction was outstanding as of September 30, 2022. Prior to September 30, 2022, and in connection with the close of the overallotment on October 4, 2022, the Company received $112,250 which should have been deposited into the Sponsor’s bank account. The amount was transferred to the Trust Account subsequent to quarter end. Due from Sponsor On September 22, 2022, a portion of the Initial Public Offering proceeds totaling was deposited into the Sponsor’s bank account. The Sponsor transferred which excludes a portion to pay down the Promissory Note (discussed below), to the Company on September 27, 2022. As of September 30, 2022, the outstanding balance due from the Sponsor was Promissory Note — Related Party On February 14, 2022, the Sponsor issued an unsecured promissory note to the Company (the “Promissory Note”), pursuant to which the Company may borrow up to an aggregate principal amount of $ . As of September 30, 2022, we had borrowed $ under the promissory note with our sponsor. The Promissory Note is non-interest bearing and due at the On September 1, 2022, we amended the promissory note to change the maturity date from July 31, 2022 to . Advances From Related Party The Sponsor paid certain offering costs on behalf of the Company and advanced working capital to the Company. These advances are due on demand and are non-interest bearing. For the period from July 24, 2019 (inception) through September 22, 2022, the related party paid of offering costs on behalf of the Company. Upon close of the Offering, the Company repaid the outstanding balance of $ 119,720 in full. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon consummation of a Business Combination into additional Placement Units at a price of $10.00 per Unit. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans . Administrative Support Agreement Commencing on the date of the prospectus and until completion of the Company’s Business Combination or liquidation, our Sponsor will make available, or cause to be made available, to the Company, or any successor location of Global Star Acquisition 1, certain office space, utilities and secretarial and administrative support as may be reasonably required by the Company. In exchange therefor, the Company shall pay Global Star Acquisition 1 the sum of $10,000 per month on the Listing Date and continuing monthly thereafter until the Termination Date. For the three and nine months ended September 30, 2022, the Company recorded $3,666 pursuant to this agreement. |
Commitments and Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2022 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Note 6 — Commitments and Contingencies Registration Rights The holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of common stock issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement signed on the effective date of Initial Public Offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the Company will not be required to effect or permit any registration or cause any registration statement to become effective until the securities covered thereby are released from their lock-up restrictions. The registration rights and stockholder agreement do not contain liquidated damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters 45- day option from the date of Initial Public Offering to purchase up t additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. As of September 30, 2022, the underwriters have not exercised their option. The underwriters were paid a cash underwriting discount of $ 0.20 per Unit, or $ , upon the closing of the Initial Public Offering. In addition, the underwriters are entitled to a deferred fee of $ 0.35 per Unit, or $ . The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. The underwriters reimbursed $ 800,000 to the Company for certain expenses in connection with this offering. The underwriters were also issued 100,000 shares (or 115,000 shares if the over-allotment option is exercised in full) of Class A common stock as representative shares, in connection with this offering. The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the date of the effectiveness of the registration statement of which this prospectus forms a part pursuant to Rule 5110(e)(1) of the FINRA Manual. Upon close of the Initial Public Offering, the Company recorded additional issuance costs of $69,000, the grant date fair value of the shares, with an offset to additional paid-in capital. |
Stockholders' Equity
Stockholders' Equity | 9 Months Ended |
Sep. 30, 2022 | |
Stockholders' Equity Note [Abstract] | |
Stockholders' Equity | Note 7 — Stockholders’ Equity Preferred Stock — Class A Common Stock — Class B Common Stock — per share. Holders of Class B common stock are entitled for each share. As of September 22, 2022, there wer Only holders of the Class B common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Class A common stock and holders of Class B common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering. The shares of Class B common stock will automatically convert into Class A common stock at the time of a Business Combination, or earlier at the option of the holder, on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (net of the number of shares of Class A common stock redeemed in connection with a Business Combination), excluding any shares or equity-linked securities issued or issuable to any seller of an interest in the target to us in a Business Combination. Only holders of the Common stock will have the right to vote on the election of directors prior to the Business Combination. Holders of Common stock will vote together as a single class on all matters submitted to a vote of our stockholders except as otherwise required by law. In connection with our initial business combination, we may enter into a stockholders agreement or other arrangements with the stockholders of the target or other investors to provide for voting or other corporate governance arrangements that differ from those in effect upon completion of this offering. Warrants days after the completion of a Business Combination and (b months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. warrant will be exercisable for cash or on a cashless basis, and the Company will not be obligated to issue any shares to holders seeking to exercise their warrants, unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its commercially reasonable efforts to file, and business days following a Business Combination to have declared effective, a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed. Notwithstanding the above, if the Class A common stock is at the time of any exercise of a warrant not listed on a national securities exchange such that it satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, but will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. Redemption of Warrants When the Price per Share of Class A Common Stock Equals or Exceeds $ 18.00 — Once the warrants become exercisable, the Company may redeem the outstanding Public Warrants: • in whole and not in part; • at a price of $ 0.01 • upon a minimum of days’ prior written notice of redemption, or the 30 • if, and only if, the last reported sale price of the Class A common stock equals or exceeds per share (as adjusted for stock splits, stock dividends, reorganization, recapitalizations and the like) for any trading days within a 30 -trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to warrant holders. If and when the warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. If the Company calls the Public Warrants for redemption, as described above, its management will have the option to require any holder that wishes to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of common stock issuable upon exercise of the Public Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary dividend or recapitalization, reorganization, merger or consolidation. However, except as described below, the Public Warrants will not be adjusted for issuances of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the Public Warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Public Warrants will not receive any of such funds with respect to their Public Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Warrants. Accordingly, the Public Warrants may expire worthless. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering. The Company will account for the warrants to be issued in connection with the Initial Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that the warrants described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. Rights o The Company accounts for the rights to be issued in connection with the Initial Public Offering in accordance with the guidance contained in ASC 815-40. Such guidance provides that the rights described above are not precluded from equity classification. Equity-classified contracts are initially measured at fair value (or allocated value). Subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Note 8 — Fair Value Measurements The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following table presents information about the Company’s assets and liabilities that are measured at fair value at September 22, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring basis. Description Level September 30, 2022 Assets: Cash in the Trust Account 1 $ 82,403,907 Liabilities: Overallotment Option 3 $ 44,975 The overallotment liability was accounted for as a liability in accordance with ASC 815-40 and is presented within liabilities on the condensed balance sheets. Upon initial issuance, the Company used a modified Black Scholes model to value the over-allotment liability and was classified within Level 3 of the fair value hierarchy at the measurement dates due to the use of unobservable inputs. Inherent in pricing models are assumptions related to expected share-price volatility, expected life and risk-free interest rate. The Company estimates the volatility of its common stock based on historical volatility that matches the expected remaining life of the instrument. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expected remaining life of the overallotment option. The expected life of the overallotment liability is assumed to be equivalent to the remaining contractual term. The key inputs into the Black-Scholes model were as follows for the measurement of the overallotment option: September 22, 2022 September 30, 202 2 Risk-free interest rate 2.96 % 2.96 % Expected life of warrants 0.12 years 0.10 years Expected volatility of underlying shares 1.5 % 1.5 % Dividend yield 0 % 0 % The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Overallotment Liability Fair value at January 1, 2022 $ — Initial measurement at September 22, 2022 52,594 Change in fair value (7,619 ) Fair value at September 30, 2022 $ 44,975 |
Subsequent Events
Subsequent Events | 9 Months Ended |
Sep. 30, 2022 | |
Subsequent Events [Abstract] | |
Subsequent Events | Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events other than the below that would have required recognition or disclosure in the condensed financial statements. On October 4, 2022, the Company consummated the closing of the sale of 1,200,000 additional units at a price of $10 per unit upon receiving notice of the underwriters’ election to exercise their overallotment option generating additional gross proceeds of $ 12.0 million |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2022 | |
AccountingPolicies [Line Items] | |
Basis of Presentation | Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the SEC. Certain information and note disclosures normally included in the financial statements prepared in accordance with US GAAP have been condensed. As such, the information included in these financial statements should be read in conjunction with the audited financial statements as of June 30, 2022 filed with the SEC on the Registration Statement on Form S-1 No. 333-266387) |
Emerging Growth Company | Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost, which approximates fair value. The Company had $1,397,490 in cash and no cash equivalents as of September 30, 2022. |
Cash and Marketable Securities Held in Trust Account | Cash and Marketable Securities Held in Trust Account As of September 30, 2022, substantially all of the assets held in the Trust Account were held in mutual funds. As of September 30, 2022, the balance in the Trust Account was $82,043,907. Income earned on Investments held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. |
Offering Costs associated with the Initial Public Offering | Offering Costs associated with the Initial Public Offering The Company complies with the requirements of the Financial Accounting Standards Board (“FASB”) ASC 340-10-S99-1 Expenses of Offering |
Class A Common Stock Subject to Possible Redemption | Class A Common Stock Subject to Possible Redemption The Company accounts for its Class A common stock subject to possible redemption in accordance with the guidance enumerated in ASC 480 “ Distinguishing Liabilities from Equity 30 The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable Class A common stock to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized a measurement adjustment from initial book value to redemption amount value. The change in the carrying value of redeemable Class A common stock resulted in charges against additional paid-in At September 30, 2022, the Class A common stock reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 80,000,000 Less: Transaction costs allocated to Class A common stock (4,184,017 ) Proceeds allocated to Public Rights and Warrants (456,000 ) (4,640,017 ) Plus: Remeasurement adjustment of Class A ordinary shares to redemption value 6,640,017 Class A common stock subject to possible redemption $ 82,000,000 |
Income Taxes | Income Taxes The Company complies with the accounting and reporting requirements of ASC Topic 740, “ Income Taxes ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not New Law and Changes On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance . Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. At this time, it has been determined that none of the IR Act tax provisions have an impact to the Company’s fiscal 2022 tax provision. The Company will continue to monitor for updates to the Company’s business along with guidance issued with respect to the IR Act to determine whether any adjustments are needed to the Company’s tax provision in future periods. |
Concentration of Credit Risk | Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At September 30, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. The cash at bank is $1,397,490 as of September 30, 2022. |
Net Loss Per Share | Net Loss Per Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class two-class The following table reflects the calculation of basic and diluted net loss per common stock (in dollars, except per share amounts): Three Months Ended Three Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (54,446 ) $ (154,598 ) — $ (19 ) Denominator: Basic and diluted weighted average shares outstanding 704,348 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.08 ) $ (0.08 ) (0.00 ) $ (0.00 ) Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (22,252 ) $ (187,498 ) — $ (78 ) Denominator: Basic and diluted weighted average shares outstanding 237,363 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.09 ) $ (0.09 ) (0.00 ) $ (0.00 ) |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “ Fair Value Measurements and Disclosures,” |
Derivative Financial Instruments | Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging”. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value on the grant date and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. The underwriters’ over-allotment option is deemed to be a freestanding financial instrument indexed on the contingently redeemable shares and will be accounted for as a liability pursuant to ASC 480. |
Stock-Based Compensation | Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation” (“ASC 718”), which establishes financial accounting and reporting standards for stock-based employee compensation. It defines a fair value-based method of accounting for an employee stock option or similar equity instrument. The Company recognizes all forms of stock-based payments, including stock option grants, warrants and restricted stock grants, at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. The Founder Shares were granted subject to certain performance conditions: the occurrence of a Business Combination. Compensation expense related to the Founder Shares is recognized only when the performance conditions are probable of occurrence under the applicable accounting literature in this circumstance. Stock-based compensation expenses are included in general and administrative expenses in the statement of operations. Stock-based payments issued to placement agents are classified as a direct cost of a stock offering and are recorded as a reduction in additional paid in capital. |
Recently Issued Accounting Standards | Recently Issued Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “ Debt -Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”)” Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Accounting Policies [Abstract] | |
Schedule of Class A Ordinary Shares Reflected in the Balance Sheets | At September 30, 2022, the Class A common stock reflected in the balance sheet is reconciled in the following table: Gross proceeds $ 80,000,000 Less: Transaction costs allocated to Class A common stock (4,184,017 ) Proceeds allocated to Public Rights and Warrants (456,000 ) (4,640,017 ) Plus: Remeasurement adjustment of Class A ordinary shares to redemption value 6,640,017 Class A common stock subject to possible redemption $ 82,000,000 |
Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share | The following table reflects the calculation of basic and diluted net loss per common stock (in dollars, except per share amounts): Three Months Ended Three Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (54,446 ) $ (154,598 ) — $ (19 ) Denominator: Basic and diluted weighted average shares outstanding 704,348 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.08 ) $ (0.08 ) (0.00 ) $ (0.00 ) Nine Months Ended Nine Months Ended September 30, 2022 September 30, 2021 Class A Class B Class A Class B Numerator: Basic and diluted net loss per share of common stock Allocation of net loss, as adjusted $ (22,252 ) $ (187,498 ) — $ (78 ) Denominator: Basic and diluted weighted average shares outstanding 237,363 2,000,000 — 2,000,000 Basic and diluted net loss per share of common stock $ (0.09 ) $ (0.09 ) (0.00 ) $ (0.00 ) |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 9 Months Ended |
Sep. 30, 2022 | |
Fair Value Disclosures [Abstract] | |
Schedule of Fair Value Hierarchy for Assets and Liabilities | Schedule of Fair Value Hierarchy for Assets and Liabilities Measured at Fair Value on a Recurring basis. Description Level September 30, 2022 Assets: Cash in the Trust Account 1 $ 82,403,907 Liabilities: Overallotment Option 3 $ 44,975 |
Schedule of Key Inputs into the Black-Scholes model | The key inputs into the Black-Scholes model were as follows for the measurement of the overallotment option: September 22, 2022 September 30, 202 2 Risk-free interest rate 2.96 % 2.96 % Expected life of warrants 0.12 years 0.10 years Expected volatility of underlying shares 1.5 % 1.5 % Dividend yield 0 % 0 % |
Summary of the Changes in the Fair Value of the Company's Level 3 Financial Instruments | The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: Overallotment Liability Fair value at January 1, 2022 $ — Initial measurement at September 22, 2022 52,594 Change in fair value (7,619 ) Fair value at September 30, 2022 $ 44,975 |
Description of Organization a_2
Description of Organization and Business Operations, Going Concern and Basis of Presentation - Additional Information (Detail) | 9 Months Ended | ||||||
Oct. 04, 2022 USD ($) shares | Sep. 30, 2022 USD ($) shares $ / shares | Sep. 22, 2022 USD ($) $ / shares shares | Sep. 22, 2021 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) shares $ / shares | Sep. 30, 2021 USD ($) | Dec. 31, 2021 USD ($) $ / shares | |
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Class of warrants or rights number of shares called by each warrant or right | shares | 0 | 0 | |||||
Class of warrants or rights exercise price per share | $ / shares | $ 0.033 | $ 0.033 | |||||
Proceeds from initial public offering | $ 79,200,000 | $ 0 | |||||
Payments for underwriting expense | 1,600,000 | ||||||
Deferred underwriting discount non current | $ 2,800,000 | 2,800,000 | |||||
Cash | $ 1,397,490 | $ 1,397,490 | $ 0 | ||||
Minimum percent of balance in the trust account for business combination | 90% | ||||||
Proceeds from issuance of trust preferred securities | $ 82,000,000 | ||||||
Sale of the placement units, per unit, | shares | 10.25 | 10.25 | |||||
Term of restricted investments | 185 days | 185 days | |||||
Working capital | $ 861,449 | $ 861,449 | |||||
Minimum net worth to consummate business combination | 5,000,001 | 5,000,001 | |||||
Assets held-in-trust | $ 303,600 | $ 303,600 | |||||
Share price | $ / shares | $ 10.1 | $ 10.1 | |||||
Assets held-in-trust, Noncurrent | $ 82,043,907 | $ 82,043,907 | 0 | ||||
Liabilities, current | 820,044 | 820,044 | $ 58,980 | ||||
Cash and cash equivalents, at carrying value | 1,397,500 | 1,397,500 | |||||
Working capital net | 861,400 | $ 861,400 | |||||
Minimum [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Period within which business combination shall be consummated from the consummation of initial public offer | 12 months | ||||||
Maximum [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Period within which business combination shall be consummated from the consummation of initial public offer | 21 months | ||||||
Sponsor [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Proceeds from initial public offering | $ 1,320,903 | ||||||
Due from Related Parties | 1,320,903 | ||||||
IPO [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Total transaction costs incurred in connection with initial public offering | $ 4,182,811 | ||||||
Payments for underwriting expense | 800,000 | ||||||
Deferred underwriting discount non current | $ 2,800,000 | 2,800,000 | |||||
Other offering costs | 513,811 | ||||||
Additional issuance costs | $ 69,000 | ||||||
Cash | $ 29,617 | ||||||
Over-Allotment Option [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Stock issued during the period shares | shares | 1,200,000 | 1,200,000 | 1,200,000 | ||||
Sale of stock issue price per share | $ / shares | $ 10 | ||||||
Proceeds from initial public offering | $ 12,000,000 | ||||||
Over allotment option period | 45 days | 45 days | |||||
Options, exercises in period | shares | 1,200,000 | ||||||
Over-Allotment Option [Member] | Subsequent Event [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Other offering costs | $ 412,500 | ||||||
Over-Allotment Option [Member] | Sponsor [Member] | Subsequent Event [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Stock issued during the period shares | shares | 112,250 | ||||||
Private Placement [Member] | Sponsor [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Class of warrants or rights warrants issued during the period units | shares | 456,225 | ||||||
Class of warrants or rights warrants issued issue price per warrant | $ / shares | $ 10 | ||||||
Proceeds from the issuance of warrants | $ 4,563,000 | ||||||
Private Placement [Member] | Sponsor [Member] | Subsequent Event [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Additional Units Issued During The Period To Related Party | shares | 42,000 | ||||||
Proceeds From Issuance Of Private Placement Units | $ 420,000 | ||||||
Common Class A [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Stock issued during the period shares | shares | 100,000 | ||||||
Common stock par or stated value per share | $ / shares | $ 0.0001 | $ 0.0001 | $ 0.0001 | ||||
Proceeds from initial public offering | $ 80,000,000 | ||||||
Common Class A [Member] | IPO [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Stock issued during the period shares | shares | 8,000,000 | 8,000,000 | |||||
Common stock par or stated value per share | $ / shares | $ 0.0001 | ||||||
Class of warrants or rights number of shares called by each warrant or right | shares | 1 | 1 | |||||
Class of warrants or rights exercise price per share | $ / shares | $ 11.5 | $ 11.5 | |||||
Sale of stock issue price per share | $ / shares | $ 10 | $ 10 | |||||
Proceeds from initial public offering | $ 80,000,000 | $ 80,000,000 | |||||
Common stock, conversion basis | Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”), one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share, and one Right, with each Right entitling the holder to receive one-tenth of one share of Class A Common Stock. | ||||||
Common Class A [Member] | Over-Allotment Option [Member] | |||||||
Organization Consolidation And Presentation Of Financial Statements [Line Items] | |||||||
Stock issued during the period shares | shares | 115,000 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Reflected in the Balance Sheets (Detail) - USD ($) | 9 Months Ended | |
Sep. 30, 2022 | Sep. 30, 2021 | |
Temporary Equity [Line Items] | ||
Gross proceeds | $ 79,200,000 | $ 0 |
Less: | ||
Plus: Remeasurement adjustment of Class A ordinary shares to redemption value | 6,640,017 | $ 0 |
Common Class A [Member] | ||
Temporary Equity [Line Items] | ||
Gross proceeds | 80,000,000 | |
Less: | ||
Transaction costs allocated to Class A common stock | (4,184,017) | |
Proceeds allocated to Public Rights and Warrants | (456,000) | |
Total | (4,640,017) | |
Plus: Remeasurement adjustment of Class A ordinary shares to redemption value | 6,640,017 | |
Class A common stock subject to possible redemption | $ 82,000,000 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies - Schedule of Calculation of Basic and Diluted Net Income (Loss) Per Ordinary Share (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2022 | Jun. 30, 2022 | Mar. 31, 2022 | Sep. 30, 2021 | Jun. 30, 2021 | Mar. 31, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | ||
Numerator: Basic and diluted net loss per share of common stock | |||||||||
Allocation of net loss, as adjusted | $ (209,044) | $ 2 | $ (708) | $ (19) | $ 0 | $ (59) | $ (209,750) | $ (78) | |
Common Class A [Member] | |||||||||
Numerator: Basic and diluted net loss per share of common stock | |||||||||
Allocation of net loss, as adjusted | $ (54,446) | $ 0 | $ (22,252) | $ 0 | |||||
Denominator: Basic and diluted weighted average shares outstanding, basic | 704,348 | 0 | 237,363 | 0 | |||||
Denominator: Basic and diluted weighted average shares outstanding, diluted | 704,348 | 0 | 237,363 | 0 | |||||
Basic and diluted net loss per share of common stock, basic | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |||||
Basic and diluted net loss per share of common stock, diluted | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |||||
Common Class B [Member] | |||||||||
Numerator: Basic and diluted net loss per share of common stock | |||||||||
Allocation of net loss, as adjusted | $ (154,598) | $ (19) | $ (187,498) | $ (78) | |||||
Denominator: Basic and diluted weighted average shares outstanding, basic | [1],[2],[3] | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||||
Denominator: Basic and diluted weighted average shares outstanding, diluted | [1],[2],[3] | 2,000,000 | 2,000,000 | 2,000,000 | 2,000,000 | ||||
Basic and diluted net loss per share of common stock, basic | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |||||
Basic and diluted net loss per share of common stock, diluted | $ (0.08) | $ 0 | $ (0.09) | $ 0 | |||||
[1]Excludes an aggregate of up to 300,000 shares of Class B common stock subject to forfeiture if the over- allotment option is not exercised in full or in part by the underwriters (see Note 5).[2]On July 26, 2022, the Sponsor surrendered and forfeited 575,000 founder shares for no consideration following which the Sponsor holds 2,300,000 founder shares. All share amounts have been retroactively restated to reflect this surrender as discussed in Note 5.[3]Shares and the associated amounts have been retroactively restated to account for the share issuance in February 14, 2022 as discussed in Note 5. |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2022 | Aug. 16, 2022 | Sep. 30, 2022 | Sep. 30, 2022 | Sep. 22, 2022 | Dec. 31, 2021 | |
Temporary Equity [Line Items] | ||||||
Cash | $ 1,397,490 | $ 1,397,490 | $ 1,397,490 | $ 0 | ||
Cash Equivalents, at Carrying Value | 0 | 0 | 0 | |||
Investments held in the trust account | 82,043,907 | 82,043,907 | 82,043,907 | 0 | ||
Stock issued during period, value, issued for services | 69,000 | |||||
Temporary equity, carrying amount, attributable to parent | 82,000,000 | 82,000,000 | 82,000,000 | 0 | ||
Adjustments to additional paid in capital increase in carrying amount of redeemable common stock | 6,600,000 | |||||
Unrecognized tax benefits | 0 | 0 | 0 | 0 | ||
Unrecognized tax benefits, income tax penalties and interest accrued | 0 | 0 | 0 | $ 0 | ||
Cash, FDIC insured amount | $ 250,000 | 250,000 | $ 250,000 | |||
Term of restricted investments | 185 days | 185 days | ||||
On Or After First January Two Thousand And Twenty Three [Member] | Inflation Reduction Act Of Two Thousand And Twenty Two [Member] | ||||||
Temporary Equity [Line Items] | ||||||
Percentage of excise tax on certain repurchases of shares | 1% | |||||
Percentage of the fair market value of the shares repurchased at the time of the repurchase representing the excise tax amount | 1% | |||||
Common Class A [Member] | ||||||
Temporary Equity [Line Items] | ||||||
Temporary equity, carrying amount, attributable to parent | $ 82,000,000 | $ 82,000,000 | $ 82,000,000 | |||
IPO [Member] | ||||||
Temporary Equity [Line Items] | ||||||
Cash | $ 29,617 | |||||
Offering costs | $ 513,811 | |||||
Stock issued during period, shares, issued for services | 100,000 | |||||
Stock issued during period, value, issued for services | $ 69,000 |
Public Offering - Additional In
Public Offering - Additional Information (Detail) - USD ($) | 9 Months Ended | |||
Sep. 22, 2022 | Sep. 22, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | |
Disclosure Of Initial Public Offering [Line Items] | ||||
Proceeds from initial public offering | $ 79,200,000 | $ 0 | ||
Class of warrants or rights number of shares called by each warrant or right | 0 | |||
Class of warrants or rights exercise price per share | $ 0.033 | |||
Common Class A [Member] | ||||
Disclosure Of Initial Public Offering [Line Items] | ||||
Stock issued during the period shares | 100,000 | |||
Proceeds from initial public offering | $ 80,000,000 | |||
IPO [Member] | Common Class A [Member] | ||||
Disclosure Of Initial Public Offering [Line Items] | ||||
Stock issued during the period shares | 8,000,000 | 8,000,000 | ||
Sale of stock issue price per share | $ 10 | $ 10 | ||
Proceeds from initial public offering | $ 80,000,000 | $ 80,000,000 | ||
Class of warrants or rights number of shares called by each warrant or right | 1 | 1 | ||
Class of warrants or rights exercise price per share | $ 11.5 | $ 11.5 | ||
Description of number of shares called by each public right upon consummation of business combination | one-tenth of one share |
Private Placement - Additional
Private Placement - Additional Information (Detail) - Private Placement [Member] - Global Star Acquisition I LLC Sponsor [Member] | 9 Months Ended |
Sep. 30, 2022 USD ($) $ / shares shares | |
Disclosure Of Private Placement [Line Items] | |
Sale of stock, number of shares issued in transaction | shares | 456,225 |
Sale of stock, price per share | $ / shares | $ 10 |
Proceeds from issuance of private placement | $ | $ 4,563,000 |
Related Party Transactions - Ad
Related Party Transactions - Additional Information (Detail) - USD ($) | 3 Months Ended | 9 Months Ended | 38 Months Ended | |||||||||||
Oct. 04, 2022 | Sep. 27, 2022 | Sep. 22, 2022 | Sep. 19, 2022 | Apr. 05, 2022 | Feb. 14, 2022 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 30, 2022 | Sep. 30, 2021 | Sep. 22, 2022 | Nov. 14, 2022 | Jul. 26, 2022 | Dec. 31, 2021 | |
Related Party Transaction [Line Items] | ||||||||||||||
Stock issued during period, Value, Issued for services | $ 69,000 | |||||||||||||
Share price | $ 10.1 | $ 10.1 | ||||||||||||
Proceeds from note payable | $ 185,000 | $ 0 | ||||||||||||
Due to related parties | $ 119,720 | $ 119,720 | ||||||||||||
Related party transaction, selling, general and administrative expense from transaction with related party | $ 3,666 | $ 0 | 3,666 | 0 | ||||||||||
Proceeds from initial public offering | 79,200,000 | $ 0 | ||||||||||||
Due from related parties current | 10,530 | 10,530 | $ 25,000 | |||||||||||
Related Party Deposits [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Due to related parties | 0 | 0 | ||||||||||||
Proceeds from additional deposits | $ 25,000 | |||||||||||||
Officer and Director [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Per unit grant date fair value of shares transferred by related party | $ 2.3 | |||||||||||||
Aggregate value of shares transferred by related party | 1,150,000 | $ 1,150,000 | ||||||||||||
Over-Allotment Option [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Proceeds from initial public offering | $ 12,000,000 | |||||||||||||
Stock issued during the period shares | 1,200,000 | 1,200,000 | 1,200,000 | |||||||||||
Common Class B [Member] | Over-Allotment Option [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Common stock, Shares, Subject to forfeiture | 300,000 | |||||||||||||
Sponsor [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Offering costs paid by related party | $ 119,720 | |||||||||||||
Notes payable, related parties | 0 | $ 0 | $ 0 | |||||||||||
Proceeds from initial public offering | $ 1,320,903 | |||||||||||||
Due from related parties current | $ 10,530 | 10,530 | ||||||||||||
Sponsor [Member] | Promissory Note [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Debt instrument, face amount | $ 300,000 | |||||||||||||
Proceeds from note payable | $ 185,000 | |||||||||||||
Description of maturity date | earlier of July 31, 2022, or the closing of this offering. | |||||||||||||
Related party transaction, amounts of transaction | $ 1,310,373 | |||||||||||||
Sponsor [Member] | Amended Promissory Note [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Debt instrument maturity date | Dec. 31, 2022 | |||||||||||||
Sponsor [Member] | Officer and Director [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Common stock, shares issued | 500,000 | |||||||||||||
Sponsor [Member] | Over-Allotment Option [Member] | Subsequent Event [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Stock issued during the period shares | 112,250 | |||||||||||||
Sponsor [Member] | Common Class B [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Common stock, Shares subscribed but unissued | 2,875,000 | |||||||||||||
Common stock, Value, Subscriptions | $ 25,000 | |||||||||||||
Stock issued during period, Shares, Issued for services | 2,875,000 | |||||||||||||
Stock issued during period, Value, Issued for services | $ 25,000 | |||||||||||||
Stock forfeiture during the period shares | 575,000 | |||||||||||||
Stock forfeiture during the period value | $ 0 | |||||||||||||
Founder [Member] | Common Class B [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Percentage of common stock issued and outstanding | 20% | 20% | ||||||||||||
Working Capital Loans [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Debt instrument, convertible, carrying amount of equity component | $ 1,500,000 | $ 1,500,000 | ||||||||||||
Debt instrument, convertible conversion price | $ 10 | $ 10 | ||||||||||||
Administrative Support Agreement [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Related party transaction, amounts of transaction | $ 10,000 | |||||||||||||
Related party transaction, selling, general and administrative expense from transaction with related party | $ 3,666 | $ 3,666 | ||||||||||||
Sponsor and Insider [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Percentage of founder shares will not be transferred assigned or sold | 50% | |||||||||||||
Percentage of remaining founder shares will not be transferred assigned or sold | 50% | |||||||||||||
Sponsor and Insider [Member] | Share Price Equal or Exceeds 12.50 Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Share price | $ 12.5 | $ 12.5 | ||||||||||||
Number of trading days for determining the share price | 20 days | |||||||||||||
Number of consecutive days for determining the share price | 30 days | |||||||||||||
Sponsor and Insider [Member] | Three Officers [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Number of shares transferred to related party | 400,000 | |||||||||||||
Sponsor and Insider [Member] | Five Directors [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Number of shares transferred to related party | 100,000 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Detail) - USD ($) | 9 Months Ended | |||
Oct. 04, 2022 | Sep. 22, 2022 | Sep. 22, 2021 | Sep. 30, 2022 | |
Other Commitments [Line Items] | ||||
Underwriting expense paid | $ 1,600,000 | |||
Deferred underwriting commissions noncurrent | $ 2,800,000 | |||
Underwriting discount paid per unit | $ 0.2 | |||
Deferred underwriting commission per unit | $ 0.35 | |||
Reimbursement of underwriting expenses | $ 800,000 | |||
Common Class A [Member] | ||||
Other Commitments [Line Items] | ||||
Stock issued during the period shares | 100,000 | |||
Over-Allotment Option [Member] | ||||
Other Commitments [Line Items] | ||||
Over allotment option period | 45 days | 45 days | ||
Stock issued during the period shares | 1,200,000 | 1,200,000 | 1,200,000 | |
Over-Allotment Option [Member] | Common Class A [Member] | ||||
Other Commitments [Line Items] | ||||
Stock issued during the period shares | 115,000 | |||
IPO [Member] | ||||
Other Commitments [Line Items] | ||||
Underwriting expense paid | $ 800,000 | |||
Additional issuance costs | $ 69,000 | |||
IPO [Member] | Common Class A [Member] | ||||
Other Commitments [Line Items] | ||||
Stock issued during the period shares | 8,000,000 | 8,000,000 |
Stockholders' Equity - Addition
Stockholders' Equity - Additional Information (Detail) - $ / shares | 9 Months Ended | |||
Sep. 22, 2022 | Sep. 30, 2022 | Dec. 31, 2021 | Sep. 22, 2021 | |
Class of Stock [Line Items] | ||||
Preferred stock, shares authorized | 1,000,000 | 1,000,000 | ||
Preferred stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | ||
Preferred stock, shares issued | 0 | 0 | ||
Preferred stock, shares outstanding | 0 | 0 | ||
Warrants exercisable term from the date of completion of business combination | 30 days | |||
Warrants exercisable term from the closing of IPO | 12 months | |||
Number of securities called by each warrant or right | 0 | |||
Minimum lock In period to become effective after the closing of the initial business combination | 60 days | |||
Share price | $ 10.1 | |||
Public Warrants [Member] | ||||
Class of Stock [Line Items] | ||||
Minimum lock in period for SEC registration from date of business combination | 15 days | |||
Share Price Equal Or Exceeds Eighteen Rupees Per Dollar [Member] | Redemption of Warrants [Member] | ||||
Class of Stock [Line Items] | ||||
Class of warrants, redemption price per unit | $ 18 | |||
Class of warrants, redemption notice period | 30 days | |||
Share price | $ 18 | |||
Number of consecutive trading days for determining share price | 20 days | |||
Number of trading days for determining share price | 30 days | |||
Common Class A [Member] | ||||
Class of Stock [Line Items] | ||||
Common stock, shares authorized | 100,000,000 | 100,000,000 | ||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | ||
Common stock, voting rights | one vote | |||
Common stock, shares issued | 556,225 | 0 | ||
Common stock, shares outstanding | 556,225 | 0 | ||
Shares subject to possible redemption | 8,000,000 | |||
Stockholders' equity note, stock split | (1/10) | |||
Common Class A [Member] | IPO [Member] | ||||
Class of Stock [Line Items] | ||||
Common stock, par value | $ / shares | $ 0.0001 | |||
Number of securities called by each warrant or right | 1 | 1 | ||
Common Class B [Member] | ||||
Class of Stock [Line Items] | ||||
Common stock, shares authorized | 10,000,000 | 10,000,000 | ||
Common stock, par value | $ / shares | $ 0.0001 | $ 0.0001 | ||
Common stock, voting rights | one vote | |||
Common stock, shares issued | 2,300,000 | 2,300,000 | ||
Common stock, shares outstanding | 2,300,000 | 2,300,000 | 2,300,000 | |
Common Class B [Member] | Over-Allotment Option [Member] | ||||
Class of Stock [Line Items] | ||||
Shares issued, shares, share-based payment arrangement, forfeited | 300,000 | |||
Common Class B [Member] | IPO [Member] | ||||
Class of Stock [Line Items] | ||||
Common stock, threshold percentage on conversion of shares | 20% |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Fair Value Hierarchy for Assets and Liabilities (Detail) - Fair Value, Recurring [Member] | Sep. 30, 2022 USD ($) |
Level 1 [Member] | |
Assets: | |
Cash in the Trust Account | $ 82,403,907 |
Level 3 [Member] | Overallotment Option Liability [Member] | |
Liabilities: | |
Overallotment Option | $ 44,975 |
Fair Value Measurements - Sch_2
Fair Value Measurements - Schedule of Key Inputs into the Black-Scholes Model (Detail) | Sep. 30, 2022 yr | Sep. 22, 2022 yr |
Risk-free interest rate [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Derivative liability, measurement input | 2.96 | 2.96 |
Expected life of warrants [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Derivative liability, measurement input | 0.1 | 0.12 |
Expected volatility of underlying shares [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Derivative liability, measurement input | 1.5 | 1.5 |
Dividend yield [Member] | ||
Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||
Derivative liability, measurement input | 0 | 0 |
Fair Value Measurements - Summa
Fair Value Measurements - Summary of the Changes in the Fair Value of the Company's Level 3 Financial Instruments (Detail) - Level 3 [Member] - Fair Value, Recurring [Member] - Overallotment Liability [Member] | 9 Months Ended |
Sep. 30, 2022 USD ($) | |
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |
Fair value at January 1, 2022 | $ 0 |
Initial measurement at September 22, 2022 | 52,594 |
Change in fair value | (7,619) |
Fair value at September 30, 2022 | $ 44,975 |
Subsequent Events - Additional
Subsequent Events - Additional Information (Detail) - USD ($) | Oct. 04, 2022 | Sep. 30, 2022 |
Subsequent Event [Line Items] | ||
Deferred underwriting commissions noncurrent | $ 2,800,000 | |
Subsequent Event [Member] | Over-Allotment Option [Member] | ||
Subsequent Event [Line Items] | ||
Sale of stock, price per share | $ 10 | |
Proceeds from issuance or sale of equity | $ 12,000,000 | |
Offering costs | 412,500 | |
Deferred underwriting commissions noncurrent | $ 262,500 | |
Subsequent Event [Member] | Over-Allotment Option [Member] | Sponsor [Member] | ||
Subsequent Event [Line Items] | ||
Sale of stock, number of shares issued in transaction | 1,200,000 | |
Subsequent Event [Member] | Private Placement [Member] | Sponsor [Member] | ||
Subsequent Event [Line Items] | ||
Sale of stock, number of shares issued in transaction | 42,000 | |
Proceeds from issuance of private placement | $ 420,000 |